Search

Author/Creator Hsu, V.

2. FRI0482 Safety and Tolerability of MEDI-551 in Subjects with Systemic Sclerosis (SSC): Results from A Phase 1 Randomized, Placebo-Controlled Escalating Single-Dose Study. (10th June 2014)

Authors:
Schiopu, E.; Chatterjee, S.; Hsu, V.; Flor, A.; Pavlovic, D.; Patra, K.; Li, J.; McKeever, K.; Herbst, R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OP0006 Safety and efficacy of lenabasum (JBT-101) in diffuse cutaneous systemic sclerosis subjects treated for one year in an open-label extension of trial jbt101-ssc-001. (12th June 2018)

Authors:
Spiera, R.; Hummers, L.; Chung, L.; Frech, T.; Domsic, R.; Hsu, V.; Furst, D.E.; Gordon, J.; Mayes, M.; Simms, R.; Lee, E.; Dgetluck, N.; Constantine, S.; White, B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0142 Rituximab in systemic sclerosis : safety and efficacy data from the eustar network. (12th June 2018)

Authors:
Elhai, M.; Distler, O.; Smith, V.; Matucci-Cerinic, M.; Alegre-Sancho, J.J.; Truchetet, M.-E.; Braun-Moscovici, Y.; Iannone, F.; Chotchaeva, F.; Lescoat, A.; Siegert, E.; Castellví, I.; Airò, P.; Vettori, S.; Hachulla, E.; Erler, A.; Ananieva, L.; Krusche, M.; López-Longo, F.; Distler, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗